title: Is chronic HIV infection associated with venous thrombotic disease? A systematic review.
abstract: Infection with the human immunodeficiency virus (HIV) is still a major health problem world-wide. HIV infection has changed into a chronic infection with the chance of developing long-term complications. Vascular complications are frequently reported in the current literature. HIV and treatment by highly active antiretroviral therapy (HAART) are associated with many cardiovascular risk factors. An increased risk of arterial cardiovascular complications was found in a number of studies. However, data about the risk of venous thrombotic disease (VTE), including potentially fatal conditions as pulmonary embolism, were limited. In a systematic review of the literature, ten relevant epidemiological studies were identified that investigated the risk of venous thrombotic disease in HIV-infected patients. The incidence was increased two- to tenfold in comparison with a healthy population of the same age. However, these studies were mainly retrospective cohort studies that were prone to selection bias, confounding factors were not always mentioned and in all but three control populations were missing. An increased risk of venous thrombotic disease in HIV-infected patients could be explained by the presence of a hypercoagulable state, characterised by an increase in procoagulant factors, such as endothelial TF expression and thrombogenic properties of microparticles, and a decrease in anticoagulant factors, including AT III, HC II and the protein C pathway. Furthermore, the risk of VTE was associated with an increased risk of infections and autoimmune haemolytic anaemia, and was weakly associated with HAART. All together, quite some evidence pointed towards a relationship between HIV infection and venous thrombotic disease, but the association still needs to be established in properly designed epidemiological studies.
authors.affiliation: Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands. igskk@slz.nl
authors.forename: S K
authors.initials: SK
authors.lastname: Klein
authors.forename: E J
authors.initials: EJ
authors.lastname: Slim
authors.forename: M D
authors.initials: MD
authors.lastname: de Kruif
authors.forename: T T
authors.initials: TT
authors.lastname: Keller
authors.forename: H
authors.initials: H
authors.lastname: ten Cate
authors.forename: E C M
authors.initials: EC
authors.lastname: van Gorp
authors.forename: D P M
authors.initials: DP
authors.lastname: Brandjes
mesh_terms: D002908:Chronic Disease; D015331:Cohort Studies; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D015994:Incidence; D009426:Netherlands / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D020246:Venous Thrombosis / Q000150:complications / Q000453:epidemiology*